Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies-Reference-Cited by-同舟云学术

Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies

Published:2018-07-09 Issue:1 Volume:5 Page:
ISSN:2054-7072
Container-title:Journal of Clinical Movement Disorders
language:en
Short-container-title:J Clin Mov Disord

Author:

Misra Vijay P.,Trosch Richard M.,Maisonobe Pascal,Om Savary

Funder

Ipsen Pharma

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40734-018-0072-8.pdf

Reference39 articles.

1. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863–73.

2. Reichel G. Cervical dystonia: a new phenomenological classification for botulinum toxin therapy. Basal Ganglia. 2011;1:5–12.

3. Jankovic J, Tsui J, Bergeron C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism Relat Disord. 2007;13:411–6.

4. Defazio G, Jankovic J, Giel JL, Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y). 2013;3 tre-03-193-4374-2

5. Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011;18:5–18.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia;Neurology;2024-02-27

2. Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up;Journal of Neurology;2022-09-06

3. Evaluation of outcome of different neurosurgical modalities in management of cervical dystonia;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2022-05-20

4. Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice;Clinical Parkinsonism & Related Disorders;2020

5. Treatment of cervical dystonia with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice;Journal of Neurology;2019-05-02